These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 27530391)

  • 1. Prevalence of integrase inhibitor resistance mutations in Austrian patients recently diagnosed with HIV from 2008 to 2013.
    Zoufaly A; Kraft C; Schmidbauer C; Puchhammer-Stoeckl E
    Infection; 2017 Apr; 45(2):165-170. PubMed ID: 27530391
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Primary resistance to integrase strand-transfer inhibitors in Europe.
    Casadellà M; van Ham PM; Noguera-Julian M; van Kessel A; Pou C; Hofstra LM; Santos JR; Garcia F; Struck D; Alexiev I; Bakken Kran AM; Hoepelman AI; Kostrikis LG; Somogyi S; Liitsola K; Linka M; Nielsen C; Otelea D; Paraskevis D; Poljak M; Puchhammer-Stöckl E; Staneková D; Stanojevic M; Van Laethem K; Zidovec Lepej S; Clotet B; Boucher CA; Paredes R; Wensing AM;
    J Antimicrob Chemother; 2015 Oct; 70(10):2885-8. PubMed ID: 26188038
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Resistance to HIV integrase strand transfer inhibitors among clinical specimens in the United States, 2009-2012.
    Hurt CB; Sebastian J; Hicks CB; Eron JJ
    Clin Infect Dis; 2014 Feb; 58(3):423-31. PubMed ID: 24145878
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence of Integrase Strand Transfer Inhibitors Resistance Mutations in Integrase Strand Transfer Inhibitors-Naive and -Experienced HIV-1 Infected Patients: A Single Center Experience.
    De Francesco MA; Izzo I; Properzi M; Gargiulo F; Caccuri F; Quiros-Roldan E; Castelli F; Caruso A; Focà E
    AIDS Res Hum Retroviruses; 2018 Jul; 34(7):570-574. PubMed ID: 29631420
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization and structural analysis of HIV-1 integrase conservation.
    Ceccherini-Silberstein F; Malet I; D'Arrigo R; Antinori A; Marcelin AG; Perno CF
    AIDS Rev; 2009; 11(1):17-29. PubMed ID: 19290031
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Integrase strand-transfer inhibitor polymorphic and accessory resistance substitutions in patients with acute/recent HIV infection.
    Ambrosioni J; Nicolás D; Manzardo C; Agüero F; Blanco JL; Mosquera MM; Peñafiel J; Gatell JM; Marcos MA; Miró JM
    J Antimicrob Chemother; 2017 Jan; 72(1):205-209. PubMed ID: 27624569
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence of Integrase Strand Inhibitor Resistance (INSTI)in New Orleans, Louisiana, 2012-2013.
    Jeanfreau K; Sharma S; Frontini M; Khirfan M; Clark RA
    J La State Med Soc; 2015; 167(1):19-20. PubMed ID: 25978751
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Resistance to HIV integrase inhibitors.
    Mesplède T; Quashie PK; Wainberg MA
    Curr Opin HIV AIDS; 2012 Sep; 7(5):401-8. PubMed ID: 22789986
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential effects of the G118R, H51Y, and E138K resistance substitutions in different subtypes of HIV integrase.
    Quashie PK; Oliviera M; Veres T; Osman N; Han YS; Hassounah S; Lie Y; Huang W; Mesplède T; Wainberg MA
    J Virol; 2015 Mar; 89(6):3163-75. PubMed ID: 25552724
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HIV-1 integrase genotyping is reliable and reproducible for routine clinical detection of integrase resistance mutations even in patients with low-level viraemia.
    Armenia D; Fabeni L; Alteri C; Di Pinto D; Di Carlo D; Bertoli A; Gori C; Carta S; Fedele V; Forbici F; D'Arrigo R; Svicher V; Berno G; Pizzi D; Nicastri E; Sarmati L; Pinnetti C; Ammassari A; D'Offizi G; Latini A; Andreoni M; Antinori A; Ceccherini-Silberstein F; Perno CF; Santoro MM
    J Antimicrob Chemother; 2015; 70(6):1865-73. PubMed ID: 25712318
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Emergent drug resistance with integrase strand transfer inhibitor-based regimens.
    Lepik KJ; Harrigan PR; Yip B; Wang L; Robbins MA; Zhang WW; Toy J; Akagi L; Lima VD; Guillemi S; Montaner JSG; Barrios R
    AIDS; 2017 Jun; 31(10):1425-1434. PubMed ID: 28375875
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Presence of V72I, G123S and R127K Integrase Inhibitor polymorphisms could reduce ART effectiveness: a retrospective longitudinal study.
    Celotti A; Gargiulo F; Quiros-Roldan E; Properzi M; De Francesco MA; Coletto D; Caccuri F; Izzo I; Caruso A; Castelli F; Focà E
    HIV Res Clin Pract; 2020 Feb; 21(1):24-33. PubMed ID: 32141388
    [No Abstract]   [Full Text] [Related]  

  • 13. Natural polymorphism S119R of HIV-1 integrase enhances primary INSTI resistance.
    Hachiya A; Ode H; Matsuda M; Kito Y; Shigemi U; Matsuoka K; Imamura J; Yokomaku Y; Iwatani Y; Sugiura W
    Antiviral Res; 2015 Jul; 119():84-8. PubMed ID: 25956162
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Integrase Strand Transfer Inhibitor Resistance Mutations in Antiretroviral Therapy-Naive and Treatment-Experienced HIV Patients in South Korea.
    Jeong W; Jung IY; Choi H; Kim JH; Seong H; Ahn JY; Jeong SJ; Ku NS; Kim JM; Choi JY
    AIDS Res Hum Retroviruses; 2019 Feb; 35(2):213-216. PubMed ID: 30229661
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evolution of a novel pathway leading to dolutegravir resistance in a patient harbouring N155H and multiclass drug resistance.
    Hardy I; Brenner B; Quashie P; Thomas R; Petropoulos C; Huang W; Moisi D; Wainberg MA; Roger M
    J Antimicrob Chemother; 2015 Feb; 70(2):405-11. PubMed ID: 25281399
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combination of two pathways involved in raltegravir resistance confers dolutegravir resistance.
    Malet I; Thierry E; Wirden M; Lebourgeois S; Subra F; Katlama C; Deprez E; Calvez V; Marcelin AG; Delelis O
    J Antimicrob Chemother; 2015 Oct; 70(10):2870-80. PubMed ID: 26205139
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The development of novel HIV integrase inhibitors and the problem of drug resistance.
    Wainberg MA; Mesplède T; Quashie PK
    Curr Opin Virol; 2012 Oct; 2(5):656-62. PubMed ID: 22989757
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HIV-1 integrase drug-resistance mutations in Iranian treatment-experienced HIV-1-infected patients.
    Marjani A; Bokharaei-Salim F; Jahanbakhshi F; Monavari SH; Esghaei M; Kalantari S; Kiani SJ; Ataei-Pirkooh A; Fakhim A; Keyvani H
    Arch Virol; 2020 Jan; 165(1):115-125. PubMed ID: 31741096
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic diversity on the integrase region of the pol gene among HIV type 1-infected patients naive for integrase inhibitors in São Paulo City, Brazil.
    Arruda LB; Fonseca LA; Duarte AJ; Casseb J
    AIDS Res Hum Retroviruses; 2010 Jan; 26(1):105-7. PubMed ID: 20055590
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HIV type 1 integrase polymorphisms in treatment-naive and treatment-experienced HIV type 1-infected patients in Thailand where HIV type 1 subtype A/E predominates.
    Phuphuakrat A; Pasomsub E; Kiertiburanakul S; Chantratita W; Sungkanuparph S
    AIDS Res Hum Retroviruses; 2012 Aug; 28(8):937-43. PubMed ID: 21970343
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.